Trial Profile
A pilot study to investigated the role of sivelestat to prevent postoperative acute respiratory distress syndrome (ARDS) in non-small cell lung cancer (NSCLC) patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Sivelestat (Primary)
- Indications Respiratory distress syndrome
- Focus Therapeutic Use
- 10 Dec 2015 New trial record